Rate of Non-copers to Non-surgical ACL Treatment After 3 Months of Rehabilitation
1 other identifier
observational
357
1 country
1
Brief Summary
The aim is to determine the sensitivity and specificity of a screening tool to identify patients who undergo ACL reconstruction (non-copers) after 3 months of standard rehabilitation following an anterior Cruciate ligament (ACL) injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 19, 2021
CompletedFirst Submitted
Initial submission to the registry
April 8, 2021
CompletedFirst Posted
Study publicly available on registry
April 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
June 24, 2025
June 1, 2025
6.3 years
April 8, 2021
June 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients undergoing ACL reconstruction after 3 months of standard rehabilitation
Patients undergoing ACL reconstruction after 3 months of standard rehabilitation are defined as non-copers to the non-surgical treatment, which will define the sensitivity and specificity of the screening examination.
3 months
Interventions
Patients follow standard municipal rehabilitation
Eligibility Criteria
Patients will be recruited from the outpatient clinic at the Department of Orthopaedic Surgery at Vejle Hospital, Denmark
You may qualify if:
- unilateral primary ACL injury
- Index injury no older than 6 months
You may not qualify if:
- Multiligament rupture
- Large cartillage or meniscus injuries
- Scheduled ACL reconstruction within 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vejle Hospitallead
Study Sites (1)
Vejle Hospital
Vejle, Region Syddanmark, 7100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Claus Varnum, ph.d.
Vejle Hosptal
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2021
First Posted
April 19, 2021
Study Start
March 19, 2021
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2028
Last Updated
June 24, 2025
Record last verified: 2025-06